Berrin Küçüktürkmen

Dr. Berrin Küçüktürkmen

Ankara University, Ankara, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in Micro
Verified
Journal Article
Open access
PDF file
ABAyşenur Bezelya
Ayşenur Bezelya
Berrin KüçüktürkmenBerrin Küçüktürkmen
Berrin Küçüktürkmen
ABAsuman Bozkir
Asuman Bozkir
In recent years, the field of drug delivery has seen a significant shift towards the exploration and utilization of nanoparticles (NPs) as versatile carriers for therapeutic agents. With its ability to provide exact control over NPs’ characteristics, microfluidics has emerged as a potent platform for the efficient and controlled synthesis of NPs. Microfluidic devices designed for precise fluid manipulation at the micro-scale offer a unique platform for tailoring NP properties, enabling enhanced control over NP properties such as size, morphology, and size distribution while ensuring high batch-to-batch reproducibility. Microfluidics can be used to produce liposomes, solid lipid nanoparticles, polymer-based NPs, and lipid-polymer hybrid NPs, as well as a variety of inorganic NPs such as silica, metal, metal oxide, quantum dots, and carbon-based NPs, offering precise control over composition and surface properties. Its unique precision in tailoring NP properties holds great promise for advancing NP-based drug delivery systems in both clinical and industrial settings. Although challenges with large-scale production still remain, microfluidics offers a transformative approach to NP synthesis. In this review, starting from the historical development of microfluidic systems, the materials used to create the systems, microfabrication methods, and system components will be discussed in order to provide the reader with an overview of microfluidic systems. In the following, studies on the fabrication of nanoparticles such as lipid NPs, polymeric NPs, and inorganic NPs in microfluidic devices are included.

18 March 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
Berrin KüçüktürkmenBerrin Küçüktürkmen
Berrin Küçüktürkmen
WIWali Inam
Wali Inam
FHFadak Howaili
Fadak Howaili
MGMariam Gouda
Mariam Gouda
Neeraj PrabhakarNeeraj Prabhakar
Neeraj Prabhakar
Jessica M. RosenholmJessica M. Rosenholm
Jessica M. Rosenholm
Microfluidics has become a popular method for constructing nanosystems in recent years, but it can also be used to coat other materials with polymeric layers. The polymeric coating may serve as a diffusion barrier against hydrophilic compounds, a responsive layer for controlled release, or a functional layer introduced to a nanocomposite for achieving the desired surface chemistry. In this study, mesoporous silica nanoparticles (MSNs) with enlarged pores were synthesized to achieve high protein loading combined with high protein retention within the MSN system with the aid of a microfluidic coating. Thus, MSNs were first coated with a cationic polyelectrolyte, poly (diallyldimethylammonium chloride) (PDDMA), and to potentially further control the protein release, a second coating of a pH-sensitive polymer (spermine-modified acetylated dextran, SpAcDEX) was deposited by a designed microfluidic device. The protective PDDMA layer was first formed under aqueous conditions, whereby the bioactivity of the protein could be maintained. The second coating polymer, SpAcDEX, was preferred to provide pH-sensitive protein release in the intracellular environment. The optimized formulation was effectively taken up by the cells along with the loaded protein cargo. This proof-of-concept study thus demonstrated that the use of microfluidic technologies for the design of protein delivery systems has great potential in terms of creating multicomponent systems and preserving protein stability.

10 June 2024 in Macromolecular Bioscience
Verified
Journal Article
Open access
Berrin KüçüktürkmenBerrin Küçüktürkmen
Berrin Küçüktürkmen
UÖUmut Can Öz
Umut Can Öz
EEEngin Er
Engin Er
I. Jénnifer GómezI. Jénnifer Gómez
I. Jénnifer Gómez
STSeda İpEk Tekneci
Seda İpEk Tekneci
ABAsuman Bozkır
Asuman Bozkır
In recent years, multifunctional nanocarriers that provide simultaneous drug delivery and imaging have attracted enormous attention, especially in cancer treatment. In this research, a biocompatible fluorescent multifunctional nanocarrier is designed for the co‐delivery of capsaicin (CPS) and nitrogen‐doped graphene quantum dots (N‐GQDs) using the pH sensitive amphiphilic block copolymer (poly(2‐ethyl‐2‐oxazoline)‐b‐poly(ε‐caprolactone), PEtOx‐b‐PCL). The effects of the critical formulation parameters (the amount of copolymer, the concentration of poly(vinyl alcohol) (PVA) as a stabilizing agent in the inner aqueous phase, and volume of the inner phase) are evaluated to achieve optimal nanoparticle (NP) properties using Central Composite Design. The optimized NPs demonstrated a desirable size distribution (167.8 ± 1.4 nm) with a negative surface charge (−19.9 ± 0.4) and a suitable loading capacity for CPS (70.80 ± 0.05%). The CPS & N‐GQD NPs are found to have remarkable toxicity on human breast adenocarcinoma cell line (MCF‐7). The solid fluorescent signal is acquired from cells containing multifunctional NPs, according to the confocal microscope imaging results, confirming the significant cellular uptake. This research illustrates the enormous potential for cellular imaging and enhanced cancer therapy offered by multifunctional nanocarriers that combine drug substances with the novel fluorescent agents.

1 December 2020 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
UÖUmut Can Öz
Umut Can Öz
MTMete Toptaş
Mete Toptaş
Berrin KüçüktürkmenBerrin Küçüktürkmen
Berrin Küçüktürkmen
BDBurcu Devrim
Burcu Devrim
OSOngun Mehmet Saka
Ongun Mehmet Saka
ABAsuman Bozkir
Asuman Bozkir

4 December 2018 in Journal of Pharmaceutical Innovation
Verified
Journal Article
Closed access
PDF file
OSOngun Mehmet Saka
Ongun Mehmet Saka
UÖUmut Can Öz
Umut Can Öz
Berrin KüçüktürkmenBerrin Küçüktürkmen
Berrin Küçüktürkmen
BDBurcu Devrim
Burcu Devrim
ABAsuman Bozkır
Asuman Bozkır

1 September 2021 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Berrin KüçüktürkmenBerrin Küçüktürkmen
Berrin Küçüktürkmen
UÖUmut Can Öz
Umut Can Öz
MTMete Toptaş
Mete Toptaş
BDBurcu Devrim
Burcu Devrim
OSOngun Mehmet Saka
Ongun Mehmet Saka
ABAsuman Bozkır
Asuman Bozkır